Aclaris Therapeutics CEO and leadership

Dr. Walker is President and Chief Executive Officer at Aclaris Therapeutics. He is also a co-founding partner of NeXeption, LLC, a biopharmaceutical management company. He is a board certified dermatologist and serial entrepreneur with over 18 years of experience in the biopharmaceutical industry. Prior to founding Aclaris, he was co-founder, President and CEO of Vicept Therapeutics (acquired by Allergan). Dr. Walker has co-founded and led a number of life science companies: Octagon Research Solutions, a software and services provider to biopharmaceutical companies (acquired by Accenture); Trigenesis Therapeutics, a specialty dermatology company where he served as Chief Medical Officer (acquired by Dr. Reddy’s Laboratories); Cutix Inc., a commercial dermatology company that markets PreSun®, a sunscreen brand acquired from Bristol-Myers Squibb. He began his pharmaceutical industry career at Johnson and Johnson. Dr. Walker co-founded and is Vice Chairman of Alexar Therapeutics, Inc. and serves on the Board of Directors of Sebacia, Inc. He also co-founded and serves on the Board of Directors of the Dermatology Summit, an Advancing Innovation in Dermatology Conference. He previously served on the Board of Directors for Octagon and the Advisory Board of Flexible Medical Systems. Dr. Walker received his MBA from The Wharton School, University of Pennsylvania.

Frank Ruffo co-founded Aclaris and has served as Chief Financial Officer since its inception in 2012. He is a senior financial executive with more than 20 years of biotech and specialty pharmaceutical management expertise in early stage through fully commercial operations. From 2014 to 2015, Frank served part time as a financial consultant at Ralexar Therapeutics, Inc. (formerly known as Alexar Therapeutics Inc.), a specialty dermatology company. Frank also served part time as the Chief Financial Officer of VenatoRx Pharmaceuticals Inc., a pharmaceutical company, from 2011 to 2014 and the Chief Financial Officer of BioLeap, Inc. from 2010 to 2013. Prior to joining Aclaris, Frank co-founded and served as Chief Financial Officer of Vicept Therapeutics, Inc. from 2009 until its acquisition by Allergan in 2011. Prior to joining Vicept Therapeutics, from 1996 to 2008 he served as the Vice President, Finance and Controller of CollaGenex Pharmaceuticals, Inc. Frank is a certified public accountant in Pennsylvania (inactive since 2008). He received his Bachelor of Science in business administration with a major in accounting from La Salle University.

Kamil Ali-Jackson is a Board Member at PDS Biotechnology Corp; Board Member at Rosemont College; and Co-Founder, Chief Legal Officer, Chief Compliance Officer and Corporate Secretary at ACLARIS THERAPEUTICS, INC. and is based in Malvern, Pennsylvania. He has worked as General Counsel and Chief Privacy Officer at CARESOFT CONSULTANCY PRIVATE LIMITED, Co-Founder at NEXEPTION LLC, and Secretary/General Counsel at Ception Therapeutics. Kamil studied at Harvard Law School between 1981 and 1984 and Princeton University between 1977 and 1981.

Mr. Christopher Powala V. is a Chief Operating Officer at ACLARIS THERAPEUTICS, INC. and is based in United States.

Dr. Walker is President and Chief Executive Officer at Aclaris Therapeutics. He is also a co-founding partner of NeXeption, LLC, a biopharmaceutical management company. He is a board certified dermatologist and serial entrepreneur with over 18 years of experience in the biopharmaceutical industry. Prior to founding Aclaris, he was co-founder, President and CEO of Vicept Therapeutics (acquired by Allergan). Dr. Walker has co-founded and led a number of life science companies: Octagon Research Solutions, a software and services provider to biopharmaceutical companies (acquired by Accenture); Trigenesis Therapeutics, a specialty dermatology company where he served as Chief Medical Officer (acquired by Dr. Reddy’s Laboratories); Cutix Inc., a commercial dermatology company that markets PreSun®, a sunscreen brand acquired from Bristol-Myers Squibb. He began his pharmaceutical industry career at Johnson and Johnson. Dr. Walker co-founded and is Vice Chairman of Alexar Therapeutics, Inc. and serves on the Board of Directors of Sebacia, Inc. He also co-founded and serves on the Board of Directors of the Dermatology Summit, an Advancing Innovation in Dermatology Conference. He previously served on the Board of Directors for Octagon and the Advisory Board of Flexible Medical Systems. Dr. Walker received his MBA from The Wharton School, University of Pennsylvania.

Frank Ruffo co-founded Aclaris and has served as Chief Financial Officer since its inception in 2012. He is a senior financial executive with more than 20 years of biotech and specialty pharmaceutical management expertise in early stage through fully commercial operations. From 2014 to 2015, Frank served part time as a financial consultant at Ralexar Therapeutics, Inc. (formerly known as Alexar Therapeutics Inc.), a specialty dermatology company. Frank also served part time as the Chief Financial Officer of VenatoRx Pharmaceuticals Inc., a pharmaceutical company, from 2011 to 2014 and the Chief Financial Officer of BioLeap, Inc. from 2010 to 2013. Prior to joining Aclaris, Frank co-founded and served as Chief Financial Officer of Vicept Therapeutics, Inc. from 2009 until its acquisition by Allergan in 2011. Prior to joining Vicept Therapeutics, from 1996 to 2008 he served as the Vice President, Finance and Controller of CollaGenex Pharmaceuticals, Inc. Frank is a certified public accountant in Pennsylvania (inactive since 2008). He received his Bachelor of Science in business administration with a major in accounting from La Salle University.

Kamil Ali-Jackson is a Board Member at PDS Biotechnology Corp; Board Member at Rosemont College; and Co-Founder, Chief Legal Officer, Chief Compliance Officer and Corporate Secretary at ACLARIS THERAPEUTICS, INC. and is based in Malvern, Pennsylvania. He has worked as General Counsel and Chief Privacy Officer at CARESOFT CONSULTANCY PRIVATE LIMITED, Co-Founder at NEXEPTION LLC, and Secretary/General Counsel at Ception Therapeutics. Kamil studied at Harvard Law School between 1981 and 1984 and Princeton University between 1977 and 1981.

Mr. Christopher Powala V. is a Chief Operating Officer at ACLARIS THERAPEUTICS, INC. and is based in United States.

Dr. Walker is President and Chief Executive Officer at Aclaris Therapeutics. He is also a co-founding partner of NeXeption, LLC, a biopharmaceutical management company. He is a board certified dermatologist and serial entrepreneur with over 18 years of experience in the biopharmaceutical industry. Prior to founding Aclaris, he was co-founder, President and CEO of Vicept Therapeutics (acquired by Allergan). Dr. Walker has co-founded and led a number of life science companies: Octagon Research Solutions, a software and services provider to biopharmaceutical companies (acquired by Accenture); Trigenesis Therapeutics, a specialty dermatology company where he served as Chief Medical Officer (acquired by Dr. Reddy’s Laboratories); Cutix Inc., a commercial dermatology company that markets PreSun®, a sunscreen brand acquired from Bristol-Myers Squibb. He began his pharmaceutical industry career at Johnson and Johnson. Dr. Walker co-founded and is Vice Chairman of Alexar Therapeutics, Inc. and serves on the Board of Directors of Sebacia, Inc. He also co-founded and serves on the Board of Directors of the Dermatology Summit, an Advancing Innovation in Dermatology Conference. He previously served on the Board of Directors for Octagon and the Advisory Board of Flexible Medical Systems. Dr. Walker received his MBA from The Wharton School, University of Pennsylvania.